Berkshire Hathaway stock: OxyChem deal closes as investors size up the Abel era

Berkshire Hathaway stock: OxyChem deal closes as investors size up the Abel era

NEW YORK, Jan 4, 2026, 14:01 ET — Market closed

Berkshire Hathaway said on Friday it completed its acquisition of Occidental Petroleum’s chemicals business OxyChem, a $9.7 billion all-cash deal that adds a major plastics and industrial chemicals producer to the conglomerate. Business Wire

The timing matters. Berkshire is entering 2026 with investors focused on how the company puts money to work after a long stretch of sitting on cash and trimming some big equity positions, even as markets remain richly valued.

It also lands as Berkshire shifts from a Warren Buffett-led story to one where capital allocation and succession are no longer theoretical. “It’s hard to imagine that there will be the same cult following,” said Brian Jacobsen, chief economic strategist at Annex Wealth Management. Reuters

Berkshire’s Class B shares closed on Friday down 1.15% at $496.85, lagging a broader market that ended modestly higher on the first trading day of 2026. Nasdaq

OxyChem’s purchase price is subject to post-closing adjustments, meaning the final bill can move based on customary balance-sheet true-ups. Occidental said an affiliate retained certain legacy tort claims and environmental liabilities tied mainly to historical operations outside the footprint of the facilities that were sold. Oxy

The deal had been announced in October as part of Occidental’s effort to cut debt after a string of big acquisitions, and it expands Berkshire’s chemical footprint beyond Lubrizol. Reuters

Even so, the $9.7 billion outlay is small next to Berkshire’s war chest, putting a spotlight back on whether the company leans into more acquisitions, steps up buybacks, or stays patient if prices don’t come down.

But there are risks. Chemicals are cyclical, and profits can swing with construction and industrial demand; investors will also watch whether the transition period brings more conservatism than markets are willing to price in.

With U.S. trading set to resume on Monday, investors will be looking for any fresh signals on capital deployment, and whether Berkshire’s next results provide a clearer read on how management wants to balance cash, buybacks and deals.

The next fixed date on the calendar is Berkshire’s shareholder meeting on May 2, which will be the first annual gathering of the new era and a key test of how the company communicates after Buffett’s handoff. Berkshirehathaway

Stock Market Today

  • Antero Midstream Valuation: Mixed Near-Term Moves, Durable Longer-Term Returns
    January 7, 2026, 6:54 PM EST. Antero Midstream (AM) closed at $17.19, with a mixed near term. The stock gained 0.2% today but slipped 3.4% in the week, and is -4.2% YTD. Still, 1-year TSR: 16% and 5-year TSR >200% point to stronger longer-term momentum. A fair-value narrative sits near $18.79, suggesting the shares are undervalued. The thesis relies on long-term exclusive contracts with Antero Resources and more than two decades of natural-gas inventory, delivering earnings visibility and margin support. Key risks: gas demand and Appalachian dynamics; production slowdowns or tighter regulation could pressure margins. The current P/E is 17.4x (above the industry 13.1x but below peers at 39.1x and our fair 19.7x), leaving some valuation risk but room for upside if results hold.
Freshworks stock drops 5% to start 2026 — what matters before Monday’s open (FRSH)
Previous Story

Freshworks stock drops 5% to start 2026 — what matters before Monday’s open (FRSH)

Consumer Cyclical Stocks wobble into Monday as Tesla drags XLY and jobs report looms
Next Story

Consumer Cyclical Stocks wobble into Monday as Tesla drags XLY and jobs report looms

Go toTop